Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody-Reference-Cited by-同舟云学术

Breast cancer imaging with radiolabelled peptide from complementarity-determining region of antitumour antibody

Published:1995-12 Issue:8991-8992 Volume:346 Page:1662-1666
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Sivolapenko G.B,Douli V,Sirmalis G,Merkouri E,Konstantinides K,Pectasides D,Skarlos D,Courtenay-Luck N.S,Epenetos A.A,Hussain R,Cook J,Courtenay-Luck N.S

Publisher

Elsevier BV

Subject

General Medicine

Reference17 articles.

1. Monoclonal antibodies for imaging and therapy;Epenetos;Br J Cancer,1989

2. Radioimmunoimaging. Quo vadis? Toward the imaging of tumor;Halpern;J Nucl Med,1990

3. Limitations of radiolabelled monoclonal antibodies for localisation of human neoplasms;Epenetos;Cancer Res,1986

4. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms;Courtenay-Luck;Cancer Res,1986

5. Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy;Schroff;Cancer Res,1995

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploration of radionuclide labeling of a novel scFv-Fc fusion protein targeting CLDN18.2 for tumor diagnosis and treatment;European Journal of Medicinal Chemistry;2024-02

2. Molecular Imaging of HER2 Expression in Breast Cancer patients Using the [99mTc] Tc-Labeled Small Peptide;Clinical Breast Cancer;2023-02

3. Downsizing antibodies: Towards complementarity-determining region (CDR)-based peptide mimetics;Bioorganic Chemistry;2022-02

4. MUC1-Targeted Radiopharmaceuticals in Cancer Imaging and Therapy;Molecular Pharmaceutics;2021-04-06

5. Preparation and evaluation of 99m Tc‐HYNIC‐ D (TPPE) as a new targeted imaging probe for detection of colon cancer: Preclinical comparison with 99m Tc‐HYNIC‐EPPT;Chemical Biology & Drug Design;2020-06-25